Vanguard FTSE Europe ETF (VEUSX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
100.20
+0.06 (0.06%)
Oct 16, 2025, 8:09 AM EDT
0.06% (1Y)
| Fund Assets | 35.09B |
| Expense Ratio | 0.08% |
| Min. Investment | $3,000 |
| Turnover | 3.00% |
| Dividend (ttm) | 2.89 |
| Dividend Yield | 2.89% |
| Dividend Growth | 14.73% |
| Payout Frequency | Quarterly |
| Ex-Dividend Date | Sep 19, 2025 |
| Previous Close | 100.14 |
| YTD Return | 28.66% |
| 1-Year Return | 20.28% |
| 5-Year Return | 77.34% |
| 52-Week Low | 78.76 |
| 52-Week High | 101.72 |
| Beta (5Y) | 1.12 |
| Holdings | 1251 |
| Inception Date | Aug 13, 2001 |
About VEUSX
The fund employs an indexing investment approach by investing all, or substantially all, of its assets in the common stocks included in the FTSE Developed Europe All Cap Index. The index is a market-capitalization-weighted index.
Fund Family Vanguard
Category Europe Stock
Stock Exchange NASDAQ
Ticker Symbol VEUSX
Share Class Admiral Shares
Index FTSE Developed Europe All Cap Net Tax (US RIC) TR
Performance
VEUSX had a total return of 20.28% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.41%.
Top 10 Holdings
16.74% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 2.09% |
| SAP SE | SAP | 2.00% |
| AstraZeneca PLC | AZN | 1.71% |
| Nestlé S.A. | NESN | 1.70% |
| Novartis AG | NOVN | 1.69% |
| Roche Holding AG | ROG | 1.63% |
| HSBC Holdings plc | HSBA | 1.61% |
| Shell plc | SHEL | 1.57% |
| Siemens Aktiengesellschaft | SIE | 1.45% |
| Novo Nordisk A/S | NOVO.B | 1.29% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 19, 2025 | $0.2561 | Sep 22, 2025 |
| Jun 20, 2025 | $1.3798 | Jun 23, 2025 |
| Mar 21, 2025 | $0.3626 | Mar 24, 2025 |
| Dec 20, 2024 | $0.8959 | Dec 23, 2024 |
| Sep 20, 2024 | $0.2094 | Sep 23, 2024 |
| Jun 21, 2024 | $1.286 | Jun 24, 2024 |